<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR88614-0094 </DOCNO><DOCID>fr.6-14-88.f2.A1093</DOCID><TEXT><ITAG tagnum="69"><ITAG tagnum="18">Drug Enforcement Administration</ITAG><ITAG tagnum="52">Manufacturer of Controlled Substances; Registration; Janssen Inc.</ITAG>By Notice dated January 6, 1988, and published in the <T4>Federal Register </T4>on January 15, 1988; (53 FR 1080), Janssen Inc.,HC 02, Box 19250, Gurabo, Puerto Rico 00658-9226, made application to theDrug Enforcement Administration to be registered as a bulk manufacturerof the basic classes of controlled substances listed below:<ITAG tagnum="110"><C>2,L2,tp0,i1,s10,9</C> <H1>Drug</H1><H1>Schedule</H1><ITAG tagnum="1">Alfentanil (9737)<D>II</D></ITAG><ITAG tagnum="1">Sufentanil (9740)<D>II</D></ITAG></ITAG>No comments or objections have been received. Therefore, pursuant to section303 of the Comprehensive Drug Abuse Prevention and Control Act of 1970and Title 21, Code of Federal Regulations, andSection; 1301.54(e), the DeputyAssistant Administrator hereby orders that the application submitted bythe above firm for registration as a bulk manufacturer of the basic classesof controlled substances listed above is granted.<ITAG tagnum="21">Dated: June 2, 1988.</ITAG><ITAG tagnum="6">Gene R. Haislip,</ITAG><ITAG tagnum="4">Deputy Assistant Administrator, Office of Diversion Control, Drug EnforcementAdministration.</ITAG><ITAG tagnum="40">[FR Doc. 88-13236 Filed 6-10-88; 8:45 am]</ITAG><ITAG tagnum="68">BILLING CODE 4410-09-M</ITAG></ITAG></TEXT></DOC>